Literature DB >> 16416176

Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey.

Francesco di Mario1, Nicoletta Stefani, Nadia Dal Bò, Massimo Rugge, Alberto Pilotto, Giulia Martina Cavestro, Lucas Giovanni Cavallaro, Angelo Franzé, Gioacchino Leandro.   

Abstract

The role of Helicobacter pylori(Hp) in functional dyspepsia (FD) is controversial and previously published data do not help to clarify whether Hp eradication affects the natural course of FD. The aim of this study was to assess the clinical course of FD during a long follow-up period of 7 years in a homogeneous sample of Hp-eradicated patients. Among patients referred between 1991 and 1996, patients with FD and infected with Hp were enrolled. Patients were administered a structured symptom questionnaire and evaluated after Hp eradication at each 12-month time points. Patients were divided into three FD subgroups: predominantly ulcer-like, dismotility-like, and reflux-like symptom clusters. A composite symptom score ranging from 0 (no symptom) to 3 (severe symptoms) was assigned to each FD cluster. Of the 1685 screened patients, 405 had FD and 211 of them (52.1%) were also Hp-positive. During the follow-up, the amount of missing information varied from 10% to 17.5% within the first 6 years and was 30.8% at 7 years. The rates of improved patients ranged from 33% (reflux-like) to 34.9% (dismotility-like) to 47.3% (ulcer-like). However, only a proportion of 10%-50% of them was symptom-free after eradication and also at each 12-month evaluation, whereas the other patients became symptomatic at different times. FD symptoms slightly improve after Hp eradication over a long period of time but a large percentage of these improved patients may experience FD symptoms again, even after some years of well-being after Hp eradication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416176     DOI: 10.1007/s10620-005-3049-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

Authors:  K McColl; L Murray; E El-Omar; A Dickson; A El-Nujumi; A Wirz; A Kelman; C Penny; R Knill-Jones; T Hilditch
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

2.  Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia.

Authors:  P D Greenberg; J P Cello
Journal:  Arch Intern Med       Date:  1999-10-25

3.  Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.

Authors:  M Lazzaroni; S Bargiggia; O Sangaletti; G Maconi; M Boldorini; G Bianchi Porro
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

4.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

Authors:  N J Talley; N Vakil; E D Ballard; M B Fennerty
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

5.  Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.

Authors:  P-I Hsu; K-H Lai; G-H Lo; H-H Tseng; C-C Lo; H-C Chen; W-L Tsai; H-S Jou; N-J Peng; C-H Chien; J-L Chen; P-N Hsu
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 6.  Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.

Authors:  P Moayyedi; S Soo; J Deeks; D Forman; A Harris; M Innes; B Delaney
Journal:  Aliment Pharmacol Ther       Date:  2003-05-15       Impact factor: 8.171

7.  Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia.

Authors:  C McCarthy; S Patchett; R M Collins; S Beattie; C Keane; C O'Morain
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

8.  Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.

Authors:  D McNamara; M Buckley; J Gilvarry; C O'Morain
Journal:  Helicobacter       Date:  2002-10       Impact factor: 5.753

Review 9.  Systemic review: the prevalence and clinical course of functional dyspepsia.

Authors:  H B El-Serag; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2004-03-15       Impact factor: 8.171

10.  Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment.

Authors:  B S Sheu; C Y Lin; X Z Lin; S C Shiesh; H B Yang; C Y Chen
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  4 in total

1.  Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.

Authors:  Ling Lan; Jing Yu; Yu-Long Chen; Ya-Li Zhong; Hao Zhang; Chang-He Jia; Yuan Yuan; Bo-Wei Liu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

2.  Quality of life in patients with functional dyspepsia: Short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: A prospective, parallel-group study.

Authors:  György M Buzás
Journal:  Curr Ther Res Clin Exp       Date:  2006-09

3.  Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography.

Authors:  Yoshiaki Matsumoto; Masanori Ito; Daisuke Kamino; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

4.  Evaluation of Helicobacter pylori eradication and drug therapy in patients with functional dyspepsia.

Authors:  Weidong Zhao; Xiaoqin Zhong; Xinying Zhuang; Hongmei Ji; Xinxin Li; Anqing Li; Ruicai Wang; Jianyou Zhu; Yanqing Li
Journal:  Exp Ther Med       Date:  2013-05-13       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.